📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-08 17:51
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
43 announcements match the current filters (relevance ≥ 5).
CRISIL Reaffirms Krishana Phoschem's Long-Term Rating at A+/Stable for Rs 1,125 Cr Bank Limits
CRISIL Ratings has reaffirmed Krishana Phoschem's long-term bank facilities rating at 'CRISIL A+/Stable' and short-term rating at 'CRISIL A1' for a total quantum of Rs 1,125 crore. Importantly, both ratings have been removed from 'Rating Watch with Developing Implications', resolving the prior rating watch overhang. Total rated facilities of Rs 1,125 crore include cash credit, term loans, and letters of credit, compared to the company's current balance sheet debt of Rs 733 crore. This reaffirmation provides stability to the company's borrowing terms and credit profile.
Confidence: HIGH
What changedCRISIL removed the company's bank facility ratings from 'Rating Watch with Developing Implications' and reaffirmed them at A+/Stable and A1.
Why it mattersResolves credit uncertainty for Rs 1,125 crore of bank facilities, supporting uninterrupted working capital access for fertilizer manufacturing and trading operations.
Total Bank Loan Facilities Rated: Rs 1125 CroreRated limits vs TTM Revenue: ~59.5%Rated limits vs Balance Sheet Debt: ~153.5%Proposed Fund-Based Bank Limits: Rs 27.26 Crore
📅 Short termPositive sentiment for credit markets and institutional lenders as rating watch uncertainty is lifted without any downgrade.
📈 Long termStable long-term credit profile at A+ ensures stable borrowing rates and credit headroom to finance working capital and capacity expansions.
⚠ Risk flags
- Relatively high leverage with D/E at 1.31 and Rs 733 crore debt on net worth of Rs 561 crore
- Fertilizer industry dependency on government subsidy disbursements and raw material price volatility
Key Highlights
CRISIL reaffirmed Long-Term Rating at 'CRISIL A+/Stable' and Short-Term Rating at 'CRISIL A1'
Ratings removed from 'Rating Watch with Developing Implications'
Total bank loan facilities rated stand at Rs 1,125 crore
Term loan allocations include Rs 75.39 crore with Axis Bank and Rs 30.23 crore with ICICI Bank
Letters of credit rated total Rs 565 crore across multiple lenders including YES Bank and ICICI Bank
👀 What to Watch
Monitor upcoming quarterly results to track interest coverage ratios and debt servicing metrics as the company ramps up DAP/NPK plant utilization.
Ishan International Notes SEBI Show Cause Notice, NSE Fine, and Approves Promoter Property Deal
Ishan International's Board met on August 22, 2026, and took note of a Show Cause Notice issued by SEBI and a fine levied by NSE for delayed compliance regarding related-party disclosures (Regulation 23(9)). The board approved a related-party transaction to purchase immovable property from Managing Director & CEO Shantanu Srivastava, alongside revisions to top management remuneration. Additionally, the company authorized executives to finalize conciliation/consent terms and noted an overdraft facility availed from Bank of India ahead of its 31st AGM.
Confidence: HIGH
What changedThe board approved a related-party property purchase from the promoter and noted regulatory actions including a SEBI Show Cause Notice and an NSE compliance penalty.
Why it mattersRegulatory scrutiny from SEBI and related-party asset transactions raise corporate governance and compliance risks for a micro-cap company (market cap ₹16 Cr).
Annual General Meeting: 31st AGMMarket Cap Context: ₹16 CrTotal Debt Context: ₹6 CrProperty Purchase Value: not disclosed
📅 Short termHeightened scrutiny on governance and regulatory developments as details regarding the SEBI notice and conciliation agreement emerge.
📈 Long termGovernance overhang and regulatory compliance resolution will remain critical for market perception and access to banking credit.
⚠ Risk flags
- Show Cause Notice from SEBI
- Penalty by NSE for delayed related-party reporting
- Related-party transaction involving property purchase from the MD & CEO
- Pending litigation/conciliation matters
Key Highlights
Noted a Show Cause Notice issued by market regulator SEBI
Noted fine levied by NSE for delayed filing under SEBI LODR Regulation 23(9)
Approved related-party purchase of immovable property from MD & CEO Shantanu Srivastava
Approved revision in remuneration for MD & CEO and Director & CFO
Authorized executives to negotiate and sign a Conciliation Agreement / Consent Terms
👀 What to Watch
Monitor upcoming disclosures and AGM resolutions for details on the SEBI show cause notice, the valuation and financial terms of the promoter property purchase, and the conciliation terms.
Q1 Revenue Up 155% YoY to ₹41.48 Cr, Net Profit Falls 49% to ₹0.16 Cr
Ishan Dyes and Chemicals reported a 154.7% YoY increase in revenue from operations to ₹41.48 cr (₹4,148.04 lakhs) for the quarter ended June 30, 2026, compared to ₹16.29 cr in the previous year. However, net profit declined 49.0% YoY to ₹0.16 cr (₹15.50 lakhs) from ₹0.30 cr, heavily compressed by higher raw material costs, finance costs (₹2.50 cr vs ₹1.26 cr YoY), and depreciation (₹2.05 cr vs ₹0.61 cr YoY). On a sequential basis, net profit fell 89.4% from ₹1.46 cr in the preceding March 2026 quarter. Additionally, statutory auditors issued a qualified conclusion on the standalone financial results.
Confidence: HIGH
What changedIshan Dyes reported standalone Q1 FY27 results featuring substantial top-line growth but sharp margin contraction and an auditor qualified conclusion.
Why it mattersSignificant top-line revenue expansion indicates product ramp-up, but higher raw material consumption, interest, and depreciation expenses have squeezed bottom-line profitability to near breakeven.
Revenue from Operations (Q1): ₹4148.04 LakhsNet Profit (Q1): ₹15.50 LakhsCost of Materials Consumed: ₹3058.80 LakhsFinance Costs: ₹249.82 LakhsDepreciation Expense: ₹204.51 LakhsBasic EPS: ₹0.06
📅 Short termNear-term sentiment may be muted due to sharp net margin contraction and the presence of an auditor qualification.
📈 Long termStructural value creation depends on the company stabilizing input cost volatilities and generating sufficient operating cash flows to offset elevated financing and depreciation costs.
⚠ Risk flags
- Qualified conclusion expressed by statutory auditors
- Severe operating margin compression
- Elevated finance and depreciation charges
Key Highlights
Revenue from operations rose 154.7% YoY to ₹4,148.04 lakhs compared to ₹1,628.83 lakhs in Q1 FY26
Net profit declined 49.0% YoY and 89.4% QoQ to ₹15.50 lakhs from ₹30.40 lakhs in Q1 FY26 and ₹146.49 lakhs in Q4 FY26
Finance costs increased to ₹249.82 lakhs (up from ₹126.33 lakhs YoY) and depreciation rose to ₹204.51 lakhs (up from ₹60.50 lakhs YoY)
Statutory auditors M/s A R Sulakhe & Co issued a Qualified Conclusion on the un-audited standalone results
33rd Annual General Meeting scheduled for Tuesday, September 29, 2026
👀 What to Watch
Review the specific nature of the auditor's qualified conclusion in the limited review report and watch for margin recovery and cost absorption as expanded capacities scale up.
SEBI issues SCN to Ishan International over ₹18.24 Cr IPO proceeds utilization
Ishan International and two of its Key Managerial Personnel (KMP) received a Show Cause Notice (SCN) from SEBI on August 10, 2026. The investigation pertains to the utilization of ₹18.24 crore raised during the company's IPO in September 2022, alleging violations of PFUTP and LODR regulations. The company has stated its intention to seek a settlement under the SEBI (Settlement Proceedings) Regulations, 2018. Given the company's small market capitalization of ₹14 crore, any significant penalty or settlement fee could be highly material.
Confidence: HIGH
What changedSEBI has formally initiated an adjudication process against the company and its management regarding the handling of IPO funds from 2022.
Why it mattersThis is a significant governance and regulatory risk; the amount under investigation (₹18.24 Cr) is larger than the company's entire current market capitalization (₹14 Cr).
IPO Proceeds under investigation: ₹18.24 crIPO Proceeds vs Market Cap: 130.2%TTM Net Profit: ₹1 crCurrent Market Cap: ₹14 crSCN Date: August 10, 2026
📅 Short termThe stock may face significant downward pressure due to the uncertainty of the SEBI investigation and the potential for financial penalties.
📈 Long termThe structural impact depends on the settlement terms; a large penalty could deplete the company's net worth (₹23 Cr) and hinder growth plans in the renewable energy sector.
⚠ Risk flags
- Regulatory action
- Governance concerns regarding IPO fund utilization
- Potential financial penalty exceeding annual profits
- Litigation against Key Managerial Personnel
Key Highlights
Investigation focuses on the utilization of ₹18.24 crore raised via IPO in September 2022
SCN alleges violations of SEBI (PFUTP) Regulations, 2003 and SEBI (LODR) Regulations, 2015
Company and two KMPs intend to apply for settlement under SEBI (Settlement Proceedings) Regulations, 2018
IPO proceeds of ₹18.24 crore represent approximately 130% of the company's current market cap of ₹14 crore
Potential penalties may be imposed under Sections 15HA and 15HB of the SEBI Act, 1992
👀 What to Watch
Investors should closely monitor the outcome of the settlement application and the final quantum of any penalty or settlement amount relative to the company's annual PAT of ₹1 crore.
4 New Sulphur-Based Products to Launch Within 3 Months at Sulphuric Acid Unit
Ishan Dyes and Chemicals has commenced work on four new high-value sulphur-based products at its Sulphuric Acid Unit. These products are expected to be commercially launched by October 2026, following a three-month development and ramp-up period. This initiative is part of a broader strategy to diversify into specialty chemicals, complementing the company's ongoing ₹70.97 Cr investment in a bulk chemical intermediates plant. The move is intended to enhance margins and strengthen market presence amidst a competitive global environment.
Confidence: HIGH
What changedThe company is expanding its product portfolio from basic chemicals and dyes into four specific high-value downstream sulphur-based products.
Why it mattersThis shift towards high-value products is critical for improving profitability and reducing vulnerability to commodity price cycles and intense competition in the basic dyes segment.
New products added: 4Launch timeline: 3 monthsOngoing project investment: ₹70.97 CrHistorical export turnover: ₹41.30 Cr
📅 Short termPositive sentiment is expected as the company moves toward commercializing new products within a short 90-day window.
📈 Long termRepresents a structural move toward becoming a more diversified specialty chemicals player, potentially re-rating the business if margin expansion is sustained.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Operational ramp-up risks
- Market acceptance of new products
- Global recessionary trends impacting export demand
Key Highlights
Commencement of work for 4 new high-value sulphur-based products
Commercial launch targeted within the next 3 months (by October 2026)
Expansion leverages the existing Sulphuric Acid Unit for value-added production
Complements the existing ₹70.97 Cr investment in a new bulk chemical intermediates plant
Aims to mitigate pricing pressures from Chinese exports and global volatility
👀 What to Watch
Investors should monitor the successful commercialization of these products by October 2026 and track subsequent quarterly results for improvements in operating margins.
54% PAT Growth in Q1 FY27; Krishana Phoschem Reports Rs 532 Cr Revenue
Krishana Phoschem reported a strong Q1 FY27 with revenue growing 35% YoY to Rs 532 Cr and PAT increasing 54% to Rs 47 Cr. Despite raw material volatility, with Sulphur prices spiking to Rs 1 lakh per tonne, the company maintained a manufacturing EBITDA margin of approximately 21% (consolidated 17%), significantly outperforming industry peers. Growth was supported by a 33% YoY increase in NPK sales and a 28% increase in SSP sales. The company also completed a 5-for-1 stock split to enhance retail liquidity.
Confidence: HIGH
What changedThe company has successfully introduced new NPK variants and executed a 5-for-1 stock split, while demonstrating margin resilience through backward integration despite high input costs.
Why it mattersThe 17% EBITDA margin significantly exceeds the 8-9% industry average, validating the company's backward integration into sulphuric and phosphoric acid as a structural competitive advantage.
Q1 FY27 Revenue: Rs 532 CrQ1 Revenue vs TTM Revenue: 39.1%Q1 FY27 PAT: Rs 47 CrNPK-DAP Sales Volume: 53,500 MTManufacturing EBITDA Margin: 21%
📅 Short termThe strong earnings growth and improved retail liquidity from the stock split are likely to be viewed positively by the market in the coming weeks.
📈 Long termLong-term growth is tied to the ramp-up of the DAP/NPK manufacturing segment and the company's ability to maintain its margin moat through backward integration.
⚠ Risk flags
- Raw material price volatility (Sulphur/Rock Phosphate)
- Geopolitical risks affecting shipping lanes (Strait of Hormuz)
- Dependency on government subsidy disbursements
Key Highlights
Revenue from operations increased 35% YoY to Rs 532 Cr for Q1 FY27
Net profit (PAT) grew 54% YoY to Rs 47 Cr, with EPS rising to Rs 1.52 from Rs 0.99
SSP unit achieved 121% capacity utilization, while the NPK-DAP unit operated at 43%
Sulphur prices surged from Rs 65,000-70,000 per tonne in April to Rs 1,00,000 per tonne by July
Introduced five new complex fertilizer variants including 12:32:16 and 9:24:24 to diversify the product mix
👀 What to Watch
Watch the capacity utilization ramp-up of the NPK-DAP unit from its current 43% level and monitor the stability of raw material costs like Sulphur and Rock Phosphate, which are sensitive to West Asia geopolitical tensions.
Rs 1125 Cr Bank Facilities Rated; CRISIL A+/A1 Maintained on 'Watch Developing'
Krishana Phoschem has received a credit rating update from CRISIL, reaffirming its 'CRISIL A+' (Long Term) and 'CRISIL A1' (Short Term) ratings. Crucially, the total rated bank facilities have been significantly enhanced by 48.8% to Rs 1,125 crore from the previous Rs 756 crore. Both ratings remain on 'Rating Watch with Developing Implications,' indicating that the credit profile is under active monitoring for potential changes. The total rated amount is substantial, representing approximately 200% of the company's net worth of Rs 561 crore.
Confidence: HIGH
What changedThe total rated bank loan facilities were increased by Rs 369 crore (a 48.8% increase), while the existing credit ratings were reaffirmed and kept on 'Watch Developing'.
Why it mattersThe enhancement provides the company with significant additional borrowing headroom to support its expansion into DAP/NPK manufacturing and its goal of reaching Rs 1,500 Cr revenue. However, the 'Watch' status indicates that the rating agency sees potential factors that could lead to a rating change in the near future.
Total Rated Facilities: Rs 1125 CrorePrevious Rated Facilities: Rs 756 CroreEnhancement Amount: Rs 369 CroreRated Facilities vs TTM Revenue: ~83%Rated Facilities vs Net Worth: ~200%
📅 Short termThe reaffirmation of the A+ rating provides some stability, but the 'Watch Developing' status may cause the stock to remain range-bound as the market awaits clarity on the credit outlook.
📈 Long termThe increased credit limits are structurally significant as they provide the liquidity necessary for the company's ramp-up of phosphatic fertilizer plants and geographical expansion into Madhya Pradesh.
⚠ Risk flags
- High Debt-to-Equity ratio (1.31)
- Rating Watch with Developing Implications indicates credit uncertainty
- High dependency on government subsidy disbursements
Key Highlights
Total bank loan facilities rated increased to Rs 1,125 crore from Rs 756 crore.
Long-term rating maintained at CRISIL A+ with a 'Watch Developing' outlook.
Short-term rating maintained at CRISIL A1 with a 'Watch Developing' outlook.
The enhanced facility amount (Rs 1,125 cr) is ~1.33x the company's current market capitalization of Rs 846 crore.
Term loans from various banks including Axis, ICICI, Shinhan, and HDFC total approximately Rs 216 crore within the rated structure.
👀 What to Watch
Monitor the resolution of the 'Watch Developing' status by CRISIL, which will clarify the direction of the company's credit profile. Investors should also track the utilization of the enhanced credit limits and its impact on the Debt-to-Equity ratio, which is already elevated at 1.31.
Ishan Dyes Proposes Exclusive Dealership with A-1 Ltd; Supplied ₹40 Cr Since Feb 2026
Ishan Dyes and Chemicals has formally proposed an exclusive dealership arrangement to A-1 Limited, a listed public company, for seven sulphur-based industrial products. The company has already established a significant relationship with A-1 Limited, supplying materials worth approximately ₹40 Crores between February 2026 and July 2026. If finalized, the arrangement is expected to enhance revenue visibility and market share, complementing the company's ongoing ₹70.97 Cr investment in a new bulk chemical intermediates plant. Currently, the proposal remains non-binding with no definitive agreement executed yet.
Confidence: HIGH
What changedThe company has moved from a standard supplier relationship to proposing a formal exclusive dealership model with a major listed client.
Why it mattersSecuring an exclusive dealership could provide a stable, high-volume sales channel for sulphur-based products, supporting the company's broader expansion into bulk chemical intermediates.
Existing supply to A-1 Ltd: ₹40 CroresNew plant investment: ₹70.97 CroresHistorical export turnover: ₹41.30 CroresSupply since Feb 2026 vs Export Turnover: ~97%
📅 Short termThe stock may see speculative interest based on the potential for a large exclusive contract, though the non-binding nature of the proposal suggests caution.
📈 Long termIf finalized, this dealership could significantly stabilize revenue and improve margins through scale, aligning with the 2025 capacity expansion goals.
⚠ Risk flags
- Non-binding proposal
- Client concentration risk
- Execution risk of the new ₹70.97 Cr plant
Key Highlights
Supplied materials worth ~₹40 Crores to A-1 Limited in the five-month period since February 2026
Proposal covers 7 products including Sulphuric Acid (98% & 70%), Oleum (23% & 65%), and Chloro Sulphonic Acid
Company is currently investing ₹70.97 Cr in a new plant for bulk chemical intermediates expected by late 2025
The proposal aims to leverage an existing distribution network and established customer base for incremental growth
👀 What to Watch
Monitor for a follow-up announcement confirming the acceptance of the proposal and the signing of a binding agreement with A-1 Limited.
Krishana Phoschem Shareholders Approve Dividend and ₹2,000 Crore Borrowing Limit
Krishana Phoschem Limited successfully concluded its 22nd Annual General Meeting on June 24, 2026, passing all 14 proposed resolutions. Shareholders approved the declaration of a dividend for the financial year 2025-26 and the re-appointment of Director Mahendra Kumar Ostwal. Most notably, the company received approval to significantly increase its borrowing powers and asset-charging limits to ₹2,000 Crores. The voting process saw a high turnout of 84.73%, with nearly 100% support for the major financial resolutions.
Key Highlights
Shareholders approved an increase in borrowing limits to ₹2,000 Crores under Section 180(1)(c).
Dividend for the financial year 2025-26 was officially declared and approved by the members.
Total votes polled reached 52.39 million, representing 84.73% of the total outstanding shares.
Limits for creating charges or security over company assets were also raised to ₹2,000 Crores.
All 14 resolutions, including the adoption of FY26 financial statements, were passed with near-unanimous support.
👀 What to Watch
The massive increase in borrowing limits to ₹2,000 Crores suggests the company is preparing for significant capital expenditure or expansion; investors should watch for upcoming project announcements. The dividend approval confirms immediate returns for shareholders.
Ishan Dyes Reports FY26 Net Loss of ₹7.11 Cr; Q4 Shows Recovery with ₹1.46 Cr Profit
Ishan Dyes and Chemicals reported a weak performance for FY26, with annual revenue from operations declining 27.6% to ₹73.47 crore from ₹101.47 crore in FY25. The company swung to a net loss of ₹7.11 crore for the full year, compared to a profit of ₹1.08 crore in the previous fiscal. However, Q4 FY26 provided some relief with a net profit of ₹1.46 crore, a significant recovery from the ₹5.25 crore loss reported in Q3 FY26. The company also announced the appointment of M/s. H D Panchal & Co. as Internal Auditors for FY27.
Key Highlights
Annual revenue from operations fell 27.6% YoY to ₹73.47 crore in FY26.
Reported a net loss of ₹7.11 crore for FY26 against a profit of ₹1.08 crore in FY25.
Q4 FY26 revenue stood at ₹31.75 crore, showing a sequential recovery from ₹18.69 crore in Q3.
Finance costs rose to ₹7.02 crore in FY26 from ₹5.13 crore in FY25.
Full-year Basic EPS declined to -₹3.00 from ₹0.52 in the previous year.
👀 What to Watch
Investors should remain cautious as the company has moved into a full-year loss despite a slight recovery in the final quarter. Monitor the sustainability of the Q4 margin improvement and revenue growth before considering long-term positions.
Krishana Phoschem Sets July 3 as Record Date for 1:5 Stock Split
Krishana Phoschem Limited has officially fixed July 3, 2026, as the record date for its stock subdivision. The company will split each existing equity share of face value ₹10 into five equity shares of face value ₹2 each. This corporate action is designed to increase the liquidity of the stock and make it more accessible to a broader base of retail investors. The adjustment in share price and quantity will reflect in portfolios following the record date.
Key Highlights
Record date for the 1:5 stock split is confirmed as July 3, 2026
Face value of equity shares to be reduced from ₹10 to ₹2 per share
Board of Directors approved the resolution on June 24, 2026
Total number of shares held by investors will increase by 5x post-split
👀 What to Watch
Existing shareholders do not need to take any action as the split is processed automatically. Potential investors should note that the stock price will adjust downwards in proportion to the 1:5 split ratio on the ex-date.
Krishana Phoschem AGM: 1:5 Stock Split Approved and Borrowing Limit Raised to ₹2000 Cr
Krishana Phoschem held its 22nd AGM on June 24, 2026, where shareholders approved a 1:5 stock split, reducing the face value from ₹10 to ₹2. The company received authorization to significantly increase its borrowing powers and asset disposal limits to ₹2000 Crores each. Additionally, a dividend for FY 2025-26 was declared, and a resolution for fresh fundraising through various instruments like QIP or private placement was passed. The meeting also ratified material related party transactions and increased the limit for loans to interested parties to ₹300 Crores.
Key Highlights
Approved 1:5 stock split, sub-dividing each ₹10 face value share into five ₹2 shares.
Increased borrowing powers and asset disposal limits to ₹2000 Crores to support future growth.
Authorized fundraising through QIP, private placement, or rights issues in supersession of earlier approvals.
Approved loans to directors or interested parties up to a revised limit of ₹300 Crores.
Declared equity dividend for FY 2025-26 and ratified material related party transactions.
👀 What to Watch
Investors should watch for the announcement of the record date for the 1:5 stock split, which is expected to improve share liquidity. The substantial increase in borrowing limits and fundraising authorization indicates the company is positioning itself for significant capital expenditure or expansion.
Ishan Dyes Reports FY26 Net Loss of ₹7.11 Cr; Auditors Issue Qualified Opinion
Ishan Dyes and Chemicals Limited reported a significant annual downturn for FY26, swinging to a net loss of ₹710.85 lakhs from a profit of ₹108.50 lakhs in FY25. Annual revenue from operations fell by approximately 27.6% to ₹7,347.13 lakhs. While Q4 FY26 showed a recovery with a net profit of ₹146.49 lakhs, the statutory auditors have issued a 'Qualified Opinion' on the financial results, necessitating a revised filing to include the Statement of Impact of Audit Qualifications.
Key Highlights
Company reported a net loss of ₹710.85 lakhs for FY26 compared to a profit of ₹108.50 lakhs in FY25.
Annual revenue from operations declined to ₹7,347.13 lakhs from ₹10,146.96 lakhs in the previous year.
Statutory Auditors M/s A R Sulakhe & Co issued a Qualified Opinion on the audited financial results.
Q4 FY26 standalone net profit stood at ₹146.49 lakhs, a turnaround from a loss of ₹116.20 lakhs in Q4 FY25.
Board appointed M/s. H D Panchal & Co. as Internal Auditors for the financial year ending March 31, 2027.
👀 What to Watch
Investors should remain cautious as the shift from profit to a substantial annual loss combined with an audit qualification are significant red flags. It is essential to review the specific details of the audit qualifications to understand the underlying accounting or operational risks.
Krishana Phoschem Reports Zero Promoter Share Encumbrance for FY Ended March 31, 2026
Krishana Phoschem Limited has filed a disclosure under Regulation 31(4) of the SEBI (SAST) Regulations for the financial year ending March 31, 2026. The filing confirms that none of the promoters or the promoter group, including persons acting in concert, have encumbered or pledged any of their shares. This annual declaration is a standard compliance requirement to ensure transparency regarding promoter holdings. The absence of pledged shares is generally viewed as a sign of financial stability within the promoter group.
Key Highlights
Compliance with Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Confirmation of zero encumbrance on shares held by promoters and promoter group as of March 31, 2026.
The disclosure includes all persons acting in concert (PAC) with the promoters.
Annual certification provides transparency regarding the lack of promoter leverage against company equity.
👀 What to Watch
Investors should take this as a positive sign of promoter confidence and financial health, as zero pledging reduces the risk of forced sell-offs. No immediate action is required other than noting the stable promoter holding structure.
Krishana Phoschem to Consider 1:5 Stock Split and ₹0.50 Dividend at AGM on June 24, 2026
Krishana Phoschem Limited has convened its 22nd Annual General Meeting for June 24, 2026, to seek shareholder approval for several key corporate actions. Most notably, the company is proposing a 1:5 stock split, reducing the face value from ₹10 to ₹2 per share to enhance liquidity. Additionally, a dividend of ₹0.50 per share (5%) has been recommended for FY 2025-26. The board is also seeking to significantly increase borrowing limits to ₹2,000 crore, suggesting potential large-scale expansion or capital requirements ahead.
Key Highlights
Proposed sub-division of 1 equity share of face value ₹10 into 5 equity shares of face value ₹2 each.
Recommendation of a ₹0.50 per share (5%) dividend for the financial year ended March 31, 2026.
Seeking approval to increase borrowing powers and creation of charges on assets up to ₹2,000 crore.
Proposal to authorize loans, guarantees, or securities to interested parties up to an aggregate of ₹300 crore.
Appointment of Mrs. Archana Dangi as an Independent Director for a five-year term starting May 2026.
👀 What to Watch
Investors should monitor the record date for the stock split and dividend, which will be announced post-AGM. The massive increase in borrowing limits to ₹2,000 crore warrants a closer look at the company's upcoming expansion plans and debt-to-equity outlook.
Ishan Dyes Q4 Net Profit at ₹1.46 Cr; FY26 Revenue Drops 27.6% YoY
Ishan Dyes and Chemicals reported a quarterly turnaround with a net profit of ₹146.49 lakhs in Q4 FY26, compared to a loss of ₹116.20 lakhs in the same period last year. However, the full-year performance for FY26 remained under pressure, posting a net loss of ₹710.85 lakhs against a profit of ₹108.50 lakhs in FY25. Annual revenue from operations saw a significant decline of 27.6%, falling to ₹7347.13 lakhs from ₹10146.96 lakhs. The company also announced the appointment of M/s H D Panchal & Co as Internal Auditors for the upcoming financial year.
Key Highlights
Q4 FY26 revenue increased significantly to ₹3175.53 lakhs from ₹1673.11 lakhs YoY.
Company achieved a Q4 net profit of ₹146.49 lakhs, recovering from a loss of ₹116.20 lakhs YoY.
Full-year FY26 revenue declined to ₹7347.13 lakhs from ₹10146.96 lakhs in FY25.
FY26 ended with a total comprehensive loss of ₹704.07 lakhs.
M/s H D Panchal & Co appointed as Internal Auditor for the financial year ending March 31, 2027.
👀 What to Watch
While the Q4 recovery is a positive sign, the substantial full-year loss and revenue decline suggest underlying business volatility; investors should wait for consistent quarterly performance before increasing exposure.
Ishan Dyes Q4 Turnaround with ₹1.46 Cr Profit; FY26 Annual Revenue Down 27.6%
Ishan Dyes and Chemicals reported a strong recovery in Q4 FY26 with revenue jumping nearly 90% YoY to ₹31.76 crore and a net profit of ₹1.46 crore, compared to a loss in the previous year's quarter. Despite the quarterly recovery, the full-year FY26 performance was weak, posting a net loss of ₹7.11 crore against a profit of ₹1.08 crore in FY25. The company significantly expanded its fixed asset base to ₹163.40 crore and raised approximately ₹45 crore through equity and warrants during the year.
Key Highlights
Q4 FY26 revenue from operations rose 89.8% YoY to ₹31.76 crore from ₹16.73 crore.
Achieved a Q4 net profit of ₹1.46 crore, reversing a net loss of ₹1.16 crore in Q4 FY25.
Full-year FY26 net loss stood at ₹7.11 crore compared to a net profit of ₹1.08 crore in FY25.
Property, Plant, and Equipment surged to ₹163.40 crore from ₹61.81 crore, indicating major capacity capitalization.
Raised ₹39.92 crore via share issuance and ₹5.39 crore through warrants to bolster the balance sheet.
👀 What to Watch
Investors should monitor if the Q4 turnaround marks a sustainable trend and how the massive increase in fixed assets translates into higher operational scale in FY27.
Krishana Phoschem Sets June 17, 2026, as Record Date for Final Dividend and 22nd AGM
Krishana Phoschem Limited has announced June 17, 2026, as the record date for determining shareholder eligibility for the final dividend of FY 2025-26. This date also serves as the cut-off for participation in the company's 22nd Annual General Meeting via e-voting. The remote e-voting period is scheduled from June 20, 2026, to June 23, 2026. Shareholders must have their bank details updated with depositories to receive the dividend credit directly into their accounts.
Key Highlights
Record date for final dividend and AGM eligibility is fixed for June 17, 2026
Remote e-voting period starts June 20, 2026 (9:00 AM) and ends June 23, 2026 (5:00 PM)
The dividend pertains to the financial year ended March 31, 2026
Cut-off date for determining voting rights at the 22nd AGM is Wednesday, June 17, 2026
👀 What to Watch
Investors seeking to qualify for the final dividend should ensure they hold the company's shares before the ex-dividend date. Additionally, shareholders should verify that their bank account details are correctly linked to their demat accounts for electronic credit.
Krishana Phoschem Approves 1:5 Stock Split and ₹1,000 Crore Fundraise
Krishana Phoschem's board has approved a 1:5 stock split, reducing the face value from ₹10 to ₹2 to enhance liquidity and retail participation. The company is seeking shareholder approval for a significant fundraise of up to ₹1,000 crore to support future expansion and long-term growth. Additionally, the board proposed increasing borrowing and asset-charging limits to ₹2,000 crore each, indicating a massive scale-up in financial capacity. A record date of June 17, 2026, has been set for the final dividend and AGM voting eligibility.
Key Highlights
Approved 1:5 stock split, converting each ₹10 face value share into five ₹2 face value shares.
Proposed a fresh fundraise of up to ₹1,000 crore through QIP, rights issue, or private placement.
Increased borrowing powers and mortgage limits under Section 180 to ₹2,000 crore each.
Set June 17, 2026, as the record date for final dividend payment and AGM e-voting.
Appointed Mrs. Archana Dangi as an Additional Non-Executive Independent Director for a 5-year term.
👀 What to Watch
Investors should watch for the AGM on June 24 for formal approval of the split and fundraise, which could act as a catalyst for the stock. The substantial increase in borrowing limits suggests an aggressive expansion phase that warrants monitoring of the company's debt-to-equity ratio.
Krishana Phoschem Approves 1:5 Stock Split and Rs 1,000 Crore Fundraise
Krishana Phoschem's board has approved a 1:5 stock split, subdividing each Rs 10 face value share into five shares of Rs 2 each to enhance market liquidity. The company is also seeking shareholder approval for a fresh fundraise of up to Rs 1,000 crore through various equity or debt instruments for future expansion. Additionally, borrowing limits have been proposed for an increase to Rs 2,000 crore to support long-term business growth. A record date of June 17, 2026, has been fixed for the final dividend and AGM eligibility.
Key Highlights
Approved 1:5 stock split, reducing share face value from Rs 10 to Rs 2 to improve retail accessibility.
Proposed fresh fundraise of up to Rs 1,000 crore via QIP, rights issue, or private placement for expansion.
Increased borrowing powers and asset charge limits to a revised cap of Rs 2,000 crore.
Set June 17, 2026, as the record date for final dividend and June 24, 2026, for the Annual General Meeting.
Appointed Mrs. Archana Dangi as an Additional Non-Executive Independent Director for a 5-year term.
👀 What to Watch
Investors should watch for the AGM approvals regarding the Rs 1,000 crore fundraise, as this indicates significant expansion plans. The stock split is likely to improve trading volumes and attract retail participation in the near term.
